Your browser doesn't support javascript.
loading
Brentuximab vedotin and bendamustine: an effective salvage therapy for relapsed or refractory Hodgkin lymphoma patients.
Uncu Ulu, Bahar; Dal, Mehmet Sinan; Yönal Hindilerden, Ipek; Akay, Olga Meltem; Mehtap, Özgür; Büyükkurt, Nurhilal; Hindilerden, Fehmi; Günes, Ahmet Kürsad; Yigenoglu, Tugçe Nur; Basci, Semih; Kizil Çakar, Merih; Yanardag Açik, Didar; Korkmaz, Serdal; Ulas, Turgay; Özet, Gülsüm; Ferhanoglu, Burhan; Nalçaci, Meliha; Altuntas, Fevzi.
Afiliação
  • Uncu Ulu B; Department of Hematology and Bone Marrow Transplantation Center, University of Health Sciences, Ankara Dr. Abdurrahman Yurtaslan Oncology Training and Research Hospital, Ankara, Turkey.
  • Dal MS; Department of Hematology and Bone Marrow Transplantation Center, University of Health Sciences, Ankara Dr. Abdurrahman Yurtaslan Oncology Training and Research Hospital, Ankara, Turkey.
  • Yönal Hindilerden I; Faculty of Medicine, Internal Medicine Department, Division of Hematology, Istanbul University, Istanbul, Turkey.
  • Akay OM; School of Medicine, Department of Hematology, Koç University, Istanbul, Turkey.
  • Mehtap Ö; Faculty of Medicine, Department of Hematology, Kocaeli University, Kocaeli, Turkey.
  • Büyükkurt N; Department of Hematology, Baskent University School of Medicine, Adana Research and Training Hospital, Adana, Turkey.
  • Hindilerden F; University of Health Sciences, Bakirköy Dr. Sadi Konuk Training and Research Hospital Hematology Clinic, Istanbul, Turkey.
  • Günes AK; Department of Hematology and Bone Marrow Transplantation, Ankara City Hospital, Ankara, Turkey.
  • Yigenoglu TN; Department of Hematology and Bone Marrow Transplantation Center, University of Health Sciences, Ankara Dr. Abdurrahman Yurtaslan Oncology Training and Research Hospital, Ankara, Turkey.
  • Basci S; Department of Hematology and Bone Marrow Transplantation Center, University of Health Sciences, Ankara Dr. Abdurrahman Yurtaslan Oncology Training and Research Hospital, Ankara, Turkey.
  • Kizil Çakar M; Department of Hematology and Bone Marrow Transplantation Center, University of Health Sciences, Ankara Dr. Abdurrahman Yurtaslan Oncology Training and Research Hospital, Ankara, Turkey.
  • Yanardag Açik D; Department of Internal Medicine and Hematology, Adana City Education and Research Hospital, Adana, Turkey.
  • Korkmaz S; Department of Hematology, University of Health Sciences, Kayseri Training and Research Hospital, Kayseri, Turkey.
  • Ulas T; School of Medicine, Department of Internal Medicine, Division of Hematology, Near East University, Nicosia, Cyprus.
  • Özet G; Department of Hematology and Bone Marrow Transplantation, Ankara City Hospital, Ankara, Turkey.
  • Ferhanoglu B; Department of Hematology and Oncology, VKV American Hospital, Istanbul, Turkey.
  • Nalçaci M; Faculty of Medicine, Internal Medicine Department, Division of Hematology, Istanbul University, Istanbul, Turkey.
  • Altuntas F; Department of Hematology and Bone Marrow Transplantation Center, University of Health Sciences, Ankara Dr. Abdurrahman Yurtaslan Oncology Training and Research Hospital, Ankara, Turkey.
J Chemother ; 34(3): 190-198, 2022 May.
Article em En | MEDLINE | ID: mdl-34514960
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doença de Hodgkin / Imunoconjugados Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: J Chemother Assunto da revista: ANTINEOPLASICOS / TERAPIA POR MEDICAMENTOS Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Turquia
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doença de Hodgkin / Imunoconjugados Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: J Chemother Assunto da revista: ANTINEOPLASICOS / TERAPIA POR MEDICAMENTOS Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Turquia